Literature DB >> 29732528

Medical Comorbidities in Bipolar Disorder.

Aktriti Sinha1, Anam Shariq2, Khaled Said2, Abhinav Sharma3, D Jeffrey Newport2, Ihsan M Salloum4.   

Abstract

PURPOSE OF REVIEW: Bipolar disorder (BD) medical comorbidity presents significant clinical and public health concerns with serious impact on health. The aim of this article is to present an updated narrative review of original research articles (case control, longitudinal cohort, and cross-sectional studies) and meta-analyses published in English language journals from January 2013 to May 2017 focusing on general medical comorbidity in BD, including the added risks of iatrogenic factors relevant to the treatment of BD. RECENT
FINDINGS: We found numerous patterns of association between BD and various medical disorders involving multiple organ systems. One pattern indicated reciprocal increase in the rate of each comorbid condition, such as an increased rate of BD in asthma or migraine, and likewise an increase in the rate of asthma or migraine in patients with BD. A second pattern was a predominantly unidirectional increase in the rate of BD in patients with certain medical disorders, such as multiple sclerosis or cerebellar diseases. A third pattern was a predominantly unidirectional increased rate of medical disorders in patients with BD. One study suggested the potential involvement of genetic mechanisms for the association between BD and migraine. Most of the studies had cross-sectional or retrospective designs, and many relied on analysis of large administrative databases inviting multiple potential biases. Our review highlights the association between BD and a variety of medical disorders. Further research is needed to elucidate the potential underlying etiopathological mechanisms that contribute to observed comorbidities. The results of this review also emphasize the need for comprehensive screening for medical disorders in BD and for adoption of an integrated model of care to address these complex comorbidities.

Entities:  

Keywords:  Bipolar disorder; Co-occurring bipolar and medical disorders; Comorbidity; Medical disorders

Mesh:

Year:  2018        PMID: 29732528     DOI: 10.1007/s11920-018-0897-8

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  59 in total

1.  The increasing medical burden in bipolar disorder.

Authors:  David J Kupfer
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

2.  Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort.

Authors:  Ophélia Godin; Bruno Etain; Chantal Henry; Thierry Bougerol; Philippe Courtet; Leroux Mayliss; Christine Passerieux; Jean-Michel Azorin; Jean-Pierre Kahn; Sebastien Gard; Dominique Costagliola; Marion Leboyer
Journal:  J Clin Psychiatry       Date:  2014-10       Impact factor: 4.384

Review 3.  A meta-analysis investigating the prevalence and moderators of migraines among people with bipolar disorder.

Authors:  Michele Fornaro; Brendon Stubbs
Journal:  J Affect Disord       Date:  2015-03-09       Impact factor: 4.839

4.  Medical comorbidity, acute medical care use in late-life bipolar disorder: a comparison of lithium, valproate, and other pharmacotherapies.

Authors:  Soham Rej; Ching Yu; Kenneth Shulman; Nathan Herrmann; Hadas D Fischer; Kinwah Fung; Andrea Gruneir
Journal:  Gen Hosp Psychiatry       Date:  2015-07-11       Impact factor: 3.238

5.  Comorbidities and mortality in bipolar disorder: a Swedish national cohort study.

Authors:  Casey Crump; Kristina Sundquist; Marilyn A Winkleby; Jan Sundquist
Journal:  JAMA Psychiatry       Date:  2013-09       Impact factor: 21.596

6.  Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Emily Katsafanas; Lucy Schweinfurth; Christina Savage; Sunil Khushalani; Robert Yolken
Journal:  J Nerv Ment Dis       Date:  2014-08       Impact factor: 2.254

7.  Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study.

Authors:  Michael E Benros; Berit L Waltoft; Merete Nordentoft; Søren D Ostergaard; William W Eaton; Jesper Krogh; Preben B Mortensen
Journal:  JAMA Psychiatry       Date:  2013-08       Impact factor: 21.596

Review 8.  Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions.

Authors:  Marianna Mazza; Marco Di Nicola; Giacomo Della Marca; Luigi Janiri; Pietro Bria; Salvatore Mazza
Journal:  Neuroscientist       Date:  2007-08       Impact factor: 7.519

9.  Risk of epilepsy after traumatic brain injury: a retrospective population-based cohort study.

Authors:  Chun-Chieh Yeh; Ta-Liang Chen; Chaur-Jong Hu; Wen-Ta Chiu; Chien-Chang Liao
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-10-31       Impact factor: 10.154

Review 10.  Significantly Higher Prevalence Rate of Asthma and Bipolar Disorder Co-Morbidity: A Meta-Analysis and Review Under PRISMA Guidelines.

Authors:  Ming-Kung Wu; Hung-Yu Wang; Yen-Wen Chen; Pao-Yen Lin; Ching-Kuan Wu; Ping-Tao Tseng
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more
  9 in total

Review 1.  Brain gyrification in bipolar disorder: a systematic review of neuroimaging studies.

Authors:  Alessandro Miola; Giulia Cattarinussi; Maria Lavinia Loré; Niccolò Ghiotto; Enrico Collantoni; Fabio Sambataro
Journal:  Brain Imaging Behav       Date:  2022-08-31       Impact factor: 3.224

2.  Electroconvulsive therapy practice during the COVID-19 pandemic.

Authors:  Helena Bellini; Eric Cretaz; Luiz Felipe Rigonatti; Carla Dominique Rodrigues De Conto; Débora Luciana Melzer-Ribeiro; Geraldo Busatto-Filho; André Russowsky Brunoni; José Gallucci-Neto
Journal:  Clinics (Sao Paulo)       Date:  2020-06-22       Impact factor: 2.365

3.  Association Between Bipolar Disorder and Low Bone Mass: A Cross-Sectional Study With Newly Diagnosed, Drug-Naïve Patients.

Authors:  Sujuan Li; Yan Qui; Ziwei Teng; Jindong Chen; Dongyu Kang; Hui Tang; Hui Xiang; Chujun Wu; Yuxi Tan; Lu Wang; Yanyi Yang; Bolun Wang; Haishan Wu
Journal:  Front Psychiatry       Date:  2020-06-10       Impact factor: 4.157

Review 4.  Antisocial Personality Disorder in Bipolar Disorder: A Systematic Review.

Authors:  Elvira Anna Carbone; Renato de Filippis; Mariarita Caroleo; Giuseppina Calabrò; Filippo Antonio Staltari; Laura Destefano; Raffaele Gaetano; Luca Steardo; Pasquale De Fazio
Journal:  Medicina (Kaunas)       Date:  2021-02-20       Impact factor: 2.430

Review 5.  Comorbid Bipolar Disorder and Migraine: From Mechanisms to Treatment.

Authors:  Jinfeng Duan; Rongmei Yang; Wenwen Lu; Lingfei Zhao; Shaohua Hu; Chenxia Hu
Journal:  Front Psychiatry       Date:  2021-01-11       Impact factor: 4.157

6.  Lithium use associated with symptom severity in comorbid bipolar disorder I and migraine.

Authors:  Nicole M Sekula; Anastasia K Yocum; Steven Anderau; Melvin G McInnis; David F Marshall
Journal:  Brain Behav       Date:  2022-05-05       Impact factor: 3.405

7.  Mood disorders, childhood maltreatment, and medical morbidity in US adults: An observational study.

Authors:  Emma K Stapp; Stacey C Williams; Luther G Kalb; Calliope B Holingue; Kathryn Van Eck; Elizabeth D Ballard; Kathleen R Merikangas; Joseph J Gallo
Journal:  J Psychosom Res       Date:  2020-07-28       Impact factor: 3.006

8.  Gender Differences in Complete Blood Count and Inflammatory Ratios among Patients with Bipolar Disorder.

Authors:  Laura Fusar-Poli; Andrea Amerio; Patriciu Cimpoesu; Pietro Grimaldi Filioli; Antimo Natale; Guendalina Zappa; Eugenio Aguglia; Mario Amore; Gianluca Serafini; Andrea Aguglia
Journal:  Brain Sci       Date:  2021-03-12

9.  The prevalence and clinical correlates of medical disorders comorbidities in patients with bipolar disorder.

Authors:  Zhonggang Wang; Tao Li; Shuhua Li; Kunkun Li; Xianfei Jiang; Chen Wei; Lei Yang; Haiyan Cao; Shen Li; Jie Li
Journal:  BMC Psychiatry       Date:  2022-03-10       Impact factor: 4.144

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.